← All organizations
Highest phase reached
Phase 3
First clinical trial
Jan 15, 2020Last known activity
Jan 1, 2026
Timeline
2010s
- Jun 1, 2018
TYK Medicines, Inc— Founded
Drugs by trial phase (15 distinct, 16 trials)
Phase 3 (2 own, 0 via acquisition)
Phase 2 (7 own, 0 via acquisition)
Indications
Studied for
Recent trials (18)
- NCT07282873Lead sponsorPhase 1/Phase 2Jan 1, 2026
- NCT07104643Lead sponsorPhase 1/Phase 2Aug 31, 2025
- NCT06672068Lead sponsorPhase 2Dec 1, 2024
- NCT06255951Lead sponsorPhase 1Mar 4, 2024
- NCT06950086Lead sponsorPhase 1/Phase 2Jan 2, 2024
- NCT06246071Lead sponsorPhase 1Jan 2, 2024
- NCT05866692Lead sponsorPhase 1Aug 17, 2023
- NCT05948813Lead sponsorPhase 2Aug 17, 2023
- NCT05866692Study directorPhase 1Aug 17, 2023
- NCT05871905Lead sponsorPhase 1Jun 25, 2023
- NCT05675605Lead sponsorPhase 1/Phase 2Apr 24, 2023
- NCT05769075Lead sponsorPhase 1Apr 20, 2023
- NCT05769075Study directorPhase 1Apr 20, 2023
- NCT05382728Lead sponsorPhase 3Jun 8, 2022
- NCT05146219Lead sponsorPhase 2Dec 31, 2021
Details
- Founded
- Shanghai, CN Jun 1, 2018
- Last known activity
- Jan 1, 2026